This webinar explores the newest developments in AI expertise and its affect on belly aortic aneurysm (AAA) detection, administration and affected person outcomes. Emphasis is positioned on a current examine showcasing the advantages of AI-based algorithms on enhancing affected person outcomes in AAA care from Yale Faculty of Medication.
Key Takeaways:
- Enhanced Detection and Monitoring: Uncover how AI algorithms robotically establish AAA on imaging and radiology experiences, making certain well timed intervention and lowered mortality danger.
- Streamlined Workflow: Be taught concerning the deployment of AI instruments as cellphone functions and desktop analytics, enabling healthcare groups to obtain real-time notifications and month-to-month affected person lists for overview.
- Comparative Evaluation: Perceive the variations in affected person care earlier than and after AI implementation, with insights into preliminary evaluations, follow-ups, and timelines for AAA repairs.
- Improved Outcomes: See the proof of elevated affected person evaluations inside 6 months and the numerous enchancment in long-term follow-up care with AI help.
- Case Research: Discover subgroup analyses that present lowered time to analysis for AAAs measuring ≥4cm and faster transitions from detection to restore for AAAs measuring ≥5cm.
Audio system:
- Uwe Fischer, MD, Vascular and Endovascular Surgeon, Yale Medication
- Edouard Aboian, MD, Vascular and Endovascular Surgeon, Yale Medication